(19)
(11) EP 3 024 841 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
27.02.2019 Bulletin 2019/09

(45) Mention of the grant of the patent:
21.11.2018 Bulletin 2018/47

(21) Application number: 14736939.1

(22) Date of filing: 03.07.2014
(51) International Patent Classification (IPC): 
C07H 15/00(2006.01)
 G01N 33/543(2006.01)
(86) International application number:
PCT/GB2014/052026
(87) International publication number:
WO 2015/011441 (29.01.2015 Gazette 2015/04)

(54)

VIRUS DETECTION

VIRUSNACHWEIS

DÉTECTION DE VIRUS

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 24.07.2013 GB 201313201

(43) Date of publication of application:
01.06.2016 Bulletin 2016/22

(73) Proprietor: Iceni Diagnostics Limited
Colney Lane Norwich, NR4 7GJ (GB)

(72) Inventors:
  • FIELD, Rob
    Norwich Norfolk NR4 7UH (GB)
  • REJZEK, Martin
    Norwich Norfolk NR4 7UH (GB)
  • RASHID, Abdul
    Norwich Norfolk NR4 7UH (GB)
  • RUSSELL, David Andrew
    Norwich Norfolk NR4 7TJ (GB)
  • MARÍN ALTABA, María José
    Norwich Norfolk NR4 7TJ (GB)

(74) Representative: Mewburn Ellis LLP 
City Tower 40 Basinghall Street
London EC2V 5DE
London EC2V 5DE (GB)


(56) References cited: : 
US-A1- 2008 194 801
   
  • M. M. RAHMAN ET AL: "Inhibitory effects and specificity of synthetic sialyldendrimers toward recombinant human cytosolic sialidase 2 (NEU2)", GLYCOBIOLOGY, vol. 23, no. 4, 30 January 2013 (2013-01-30), pages 495-504, XP055137668, ISSN: 0959-6658, DOI: 10.1093/glycob/cws221
  • YU Y P ET AL: "Recognition between a divalent sialyl molecule and wheat germ agglutinin", TETRAHEDRON LETTERS, PERGAMON, GB, vol. 50, no. 45, 11 November 2009 (2009-11-11), pages 6130-6132, XP026640484, ISSN: 0040-4039, DOI: 10.1016/J.TETLET.2009.08.073 [retrieved on 2009-08-26]
  • SLIEDREGT L A J M ET AL: "Design and synthesis of a multivalent homing device for targeting to murine CD22", BIOORGANIC & MEDICINAL CHEMISTRY, PERGAMON, GB, vol. 9, no. 1, 1 January 2001 (2001-01-01) , pages 85-97, XP002609895, ISSN: 0968-0896, DOI: 10.1016/S0968-0896(00)00224-8 [retrieved on 2000-12-15]
  • VEENEMAN G H ET AL: "Synthesis of sialic acid-lipid conjugates and their neuritogenic effects on N1E.115 neuroblastoma cells", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, AMSTERDAM, NL, vol. 5, no. 1, 5 January 1995 (1995-01-05) , pages 9-14, XP004135779, ISSN: 0960-894X, DOI: 10.1016/0960-894X(94)00450-T
  • CAROLINE PAPIN ET AL: "Fast Access to Robust C -Sialoside Multimers", CHEMISTRY - A EUROPEAN JOURNAL, vol. 15, no. 1, 1 January 2009 (2009-01-01), pages 53-57, XP055137527, ISSN: 0947-6539, DOI: 10.1002/chem.200801810
  • EARLE M A ET AL: "Chemoenzymatic synthesis of a trimeric ganglioside GM3 analogue", CARBOHYDRATE RESEARCH, PERGAMON, GB, vol. 301, no. 1-2, 11 June 1997 (1997-06-11), pages 1-4, XP004075621, ISSN: 0008-6215, DOI: 10.1016/S0008-6215(97)00085-2
  • S. J. GAMBLIN ET AL: "Influenza Hemagglutinin and Neuraminidase Membrane Glycoproteins", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 285, no. 37, 10 September 2010 (2010-09-10), pages 28403-28409, XP055137495, ISSN: 0021-9258, DOI: 10.1074/jbc.R110.129809 cited in the application
  • Y. P. LIN ET AL: "Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 109, no. 52, 26 December 2012 (2012-12-26), pages 21474-21479, XP055137475, ISSN: 0027-8424, DOI: 10.1073/pnas.1218841110 cited in the application
  • MARÍA J. MARÍN ET AL: "Glyconanoparticles for the plasmonic detection and discrimination between human and avian influenza virus", ORGANIC & BIOMOLECULAR CHEMISTRY, vol. 11, no. 41, 3 September 2013 (2013-09-03), page 7101, XP055137481, ISSN: 1477-0520, DOI: 10.1039/c3ob41703d
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).